Cancer Share to Facebook Share to Twitter Share to LinkedIn Share via Email Michael Liptay, MD, a thoracic surgeon at Rush University Medical Center in Chicago, explains why lung cancer has become increasingly treatable. Lung Cancer Content Hub Video
Cancer New Potential Immunotherapies for Pancreatic Cancer Scientists at RUSH who have discovered two new targets for decreasing the progression of pancreatic cancer.
Cancer Coming Together to Support Cancer Research Family-owned West Side company Roscoe raises funds to support...
Cancer Frontline Treatments for Non-muscle Invasive and Invasive Bladder Cancer with Gary Steinberg, MD Gary Steinberg, MD, is a urologist at RUSH and a national...